<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>ABSTRACT: <z:chebi fb="3" ids="3638">Chloroquine</z:chebi> and hydroxychloroquine are used to chronically treat certain rheumatologic diseases and are generally considered safe </plain></SENT>
<SENT sid="1" pm="."><plain>We describe 2 patients with <z:hpo ids='HP_0003756'>skeletal myopathy</z:hpo> and fatal <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>-uncommon and underrecognized adverse effects of these agents </plain></SENT>
<SENT sid="2" pm="."><plain>Both patients developed <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> and <z:hpo ids='HP_0001635'>heart failure</z:hpo>, and 1 patient had documented diaphragmatic involvement </plain></SENT>
<SENT sid="3" pm="."><plain>Muscle specimens showed typical vacuolar <z:hpo ids='HP_0003198'>myopathy</z:hpo> (indicative of impaired autophagy) with myeloid bodies in both patients and curvilinear bodies in 1 patient </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="1" ids="38068">Antimalarial</z:chebi>-induced <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> should be considered in patients receiving these medications with otherwise unexplained <z:hpo ids='HP_0001324'>muscle weakness</z:hpo> or cardiac symptoms </plain></SENT>
<SENT sid="5" pm="."><plain>Whether autophagy enhancers can be used to manage such <z:hpo ids='HP_0003198'>myopathies</z:hpo> merits investigation </plain></SENT>
</text></document>